From: Prevalence and risk factors associated with drug-resistant epilepsy in adult epileptic patients
Univariate | #Multivariate | |||
---|---|---|---|---|
p | OR (95%CI) | p | OR (95%CI) | |
Female | 0.570 | 1.166 (0.687–1.979) | ||
Age (years) | 0.007* | 0.974 (0.955–0.993) | 0.421 | 0.990 (0.966–1.014) |
Age of onset (< 10 years) | < 0.001* | 4.022 (2.152–7.517) | 0.058 | 2.097 (0.975–4.509) |
Epilepsy duration | 0.137 | 1.017 (0.995–1.039) | ||
Focal seizure type | 0.334 | 1.319 (0.752–2.311) | ||
Initial frequency (daily/weekly) | 0.003* | 2.277 (1.316–3.941) | 0.683 | 1.293 (.377–4.429) |
Max-free period (< 2 years) | < 0.001* | 5.501 (2.355–12.851) | < 0.001* | 26.738 (7.374–96.951) |
History of neonatal seizures | 0.628 | 1.240 (0.519–2.962) | ||
history of Febrile S | 0.775 | 1.102 (0.566–2.147) | ||
History of SE | 0.002* | 2.987 (1.511–5.905) | 0.331 | 1.697 (0.584–4.928) |
Duration till AED use Delayed | 0.217 | 1.675 (0.739–3.800) | ||
Bad response to 1st AED | < 0.001* | 2.676 (1.554–4.609) | 0.035* | 4.366 (1.111–17.155) |
History of neurological insult | 0.261 | 1.378 (0.787–2.413) | ||
Etiology | ||||
Structural/metabolic | 0.024* | 1.848 (1.082–3.156) | 0.075 | 0.340 (0.104–1.114) |
Genetic | 0.600 | 1.186 (.628–2.241) | ||
Abnormal EEG | < 0.001* | 3.364 (1.913–5.916) | 0.135 | 2.358 (0.767–7.252) |
Abnormal imaging findings | 0.669 | 0.882 (0.497–1.567) | ||
Developmental delay | 0.141 | 1.583 (.859–2.918) |